Abstract:A post‐SELEX modification strategy is employed, incorporating truncation and mutagenesis to engineer the VCM parent aptamer. This yields a VCM aptamer (ABC20‐11) that features an intramolecular G‐triplex, enhanced thioflavin T fluorescence intensity, and improved affinity (Kd = 0.591 × 10−6 m) and specificity (at the one‐methyl level) for VCM. Leveraging these properties, a label‐free, single‐step, rapid fluorescent aptasensor is developed for the detection of VCM. Currently, the reported vancomycin (VCM) aptamers, including the 3‐ (Kd = 9.13 × 10−6 m) and 4‐truncated variants (Kd = 45.5 × 10−6 m), are engineered via stem truncation of the VCM parent aptamer, which inevitably compromises their affinities, thus affecting their clinical application within the VCM therapeutic window of 6.9–13.8 × 10−6 m. Herein, the binding pocket of the VCM parent aptamer is elucidated for the first time and we implemented the Post‐SELEX modification strategy involving truncation and mutagenesis to refined the VCM parent aptamer. This yielded a VCM aptamer (ABC20‐11) with an intramolecular G‐triplex, an enhanced thioflavin T (ThT) fluorescence intensity, and an improved affinity (Kd = 0.591 × 10−6 m) and specificity (one‐methyl level) for VCM. Utilizing a portable fluorescence detector specifically designed for rapidly detecting VCM concentration and leveraging the competitive binding between VCM and ThT to ABC20‐11, a label‐free fluorescent aptasensor is developed. This aptasensor exhibits exceptional analytical performances across various clinical samples (serum, cerebrospinal fluid, and joint fluid), with corresponding linear ranges of 0.5–50, 0.5–40, and 0.5–50 × 10−6 m and detection limits at 0.11, 0.12, and 0.16 × 10−6 m, respectively. Consequently, the proposed VCM aptasensor displays considerable clinical value and potential for use in rapid VCM detection.

Dual-emission Fluorescence Biosensing of Vancomycin Based on AIEgen–peptide Conjugates and Aptamer-Modified Au Nanoclusters

A ratiometric fluorescent probe for sensitive determination of the important glycopeptide antibiotic vancomycin

Fluorimetric monitoring of vancomycin using an allosteric probe-initiated sensing platform

Dual-Recognition Förster Resonance Energy Transfer Based Platform for One-Step Sensitive Detection of Pathogenic Bacteria Using Fluorescent Vancomycin-Gold Nanoclusters and Aptamer-Gold Nanoparticles.

Engineered Aptamer‐Derived Fluorescent Aptasensor: the Label‐Free, Single‐Step, Rapid Detection of Vancomycin in Clinical Samples

A Fluorescence Biosensor for Therapeutic Drug Monitoring of Vancomycin Using in Vivo Microdialysis.

A simple and rapid strategy for monitoring vancomycin concentration in serum using a multicolor immunosensor based on the ratio of gold nanobipyramids and a product of cetyltrimethylammonium bromide-blue oxide of 3,3',5,5'-tetramethylbenzidine interaction

Rapid Monitoring of Vancomycin Concentration in Serum Using Europium (III) Chelate Nanoparticle-Based Lateral Flow Immunoassay

Sandwich Fluorimetric Method for Specific Detection of Staphylococcus Aureus Based on Antibiotic-Affinity Strategy

Electron transfer and fluorescence “turn-off” based CdTe quantum dots for vancomycin detection at nanogram level in aqueous serum media

Using Sensitive Surface Plasmon Resonance to Detect Binding of Peptide Molecules and Immobilized Vancomycin

Fluorescent Aptasensor for Antibiotic Detection Using Magnetic Bead Composites Coated with Gold Nanoparticles and a Nicking Enzyme.

A Novel Label-Free Dual-Mode Aptasensor Based on the Mutual Regulation of Silver Nanoclusters and MoSe2 Nanosheets for Reliable Detection of Ampicillin.

Highly sensitive SERS nanoplatform based on aptamer and vancomycin for detection of S. aureus and its clinical application

Gold Nanocluster-Based Fluorescent Sensor Array for Antibiotic Sensing and Identification

Establishment of an Ultrasensitive Indirect Competitive Time-Resolved Fluoroimmunoassay for Vancomycin Determination

Dual-recognition Detection of Staphylococcus Aureus Using Vancomycin-Functionalized Magnetic Beads As Concentration Carriers.

Hybrid Peptide-Molecularly Imprinted Polymer Interface for Electrochemical Detection of Vancomycin in Complex Matrices

A Biochemical Lanthanide-Encoding Approach Enables Quantitative Monitoring of the Bacterial Response to Vancomycin Treatment.

Signal "on-off" photoelectrochemical biosensor for gram-positive bacteria quick detection based on vancomycin functionalized BiVO 4 /Au photoelectrode

Aggregation-Resistant, Turn-On-Off Fluorometric Sensing of Glutathione and Nickel (II) Using Vancomycin-Conjugated Gold Nanoparticles